PRKAR1B: A Potential Drug Target and Biomarker (G5575)

Target Name: PRKAR1B

NCBI ID: G5575

Other Name(s): protein kinase, cAMP-dependent, regulatory, type I, beta | KAP1_HUMAN | Protein kinase cAMP-dependent type I regulatory subunit beta, transcript variant 2 | protein kinase cAMP-dependent type I regulatory subunit beta | MASNS | PRKAR1B variant 1 | cAMP-dependent protein kinase type I-beta regulatory subunit | OTTHUMP00000199952 | protein kinase, cAMP-dependent, regulatory subunit type I beta | Protein kinase, cAMP-dependent, regulatory, type I, beta, transcript variant 1 | CAMP-dependent protein kinase type I-beta regulatory subunit | PRKAR1B variant 2 | Homo sapiens protein kinase cAMP-dependent type I regulatory subunit beta, transcript variant 5 | PRKAR1

PRKAR1B: A Potential Drug Target and Biomarker

PRKAR1B, also known as protein kinase, cAMP-dependent, regulatory, type I, beta, is a protein that plays a crucial role in cellular signaling pathways. It is a non-catalytic protein that is primarily located in the cytoplasm and has been identified as a potential drug target in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The protein kinase pathway is a well-established signaling pathway that is involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation. The pathway is activated by the cAMP molecule, which is produced by the likes of protein kinase A, which is a key enzyme in the pathway. The cAMP molecule then activates protein kinase B, which is the protein kinase that is targeted by PRKAR1B.

PRKAR1B is a protein that is highly conserved across various species, including humans. It is found in various cellular compartments, including the cytoplasm, mitochondria, and endoplasmic reticulum. It is a 21-kDa protein that has a molecular weight of 43 kDa and a calculated pI of 6.5. PRKAR1B has a unique structure that is composed of a 21 amino acid chain with a calculated molecular weight of 43 kDa.

PRKAR1B is a non-catalytic protein that is primarily located in the cytoplasm. It has been shown to interact with various cellular components, including the cytoplasmic matrix, the endoplasmic reticulum, and the mitochondria. PRKAR1B has also been shown to play a role in the regulation of cellular processes, including cell growth, apoptosis, and inflammation.

One of the most significant functions of PRKAR1B is its role in the regulation of cAMP signaling pathways. It is a key enzyme in the cAMP-dependent signaling pathway, which is involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation. The cAMP molecule is produced by the likes of protein kinase A, which is a key enzyme in the pathway. Once produced, the cAMP molecule binds to PRKAR1B, which then activates protein kinase B, the protein kinase that is targeted by PRKAR1B.

PRKAR1B has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. For example, studies have shown that PRKAR1B plays a role in the regulation of cell cycle progression, cell apoptosis, and the regulation of inflammation.

In addition to its role in the regulation of cAMP signaling pathways, PRKAR1B has also been shown to play a role in the regulation of various cellular processes, including cell adhesion, migration, and the regulation of cytoskeletal structure. For example, studies have shown that PRKAR1B plays a role in the regulation of cell adhesion, as well as the regulation of cytoskeletal structure.

PRKAR1B has also been shown to have potential therapeutic applications in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that PRKAR1B is involved in the regulation of cancer cell growth and has the potential to be a therapeutic target for cancer. Additionally, PRKAR1B has also been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease, and has the potential to be a therapeutic target for these diseases.

In conclusion, PRKAR1B is a protein that plays a crucial role in cellular signaling pathways. It is a non-catalytic protein that is primarily located in the cytoplasm and has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of PRKAR1B in cellular signaling pathways and its potential therapeutic applications.

Protein Name: Protein Kinase CAMP-dependent Type I Regulatory Subunit Beta

Functions: Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells

More Common Targets